Contributions on the topics listed in the Conference Announcement under Section C are welcome as oral or poster presentations. All submissions, apart from invited papers, must present original work, ...
WILMINGTON, Del., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) ("Prelude” or the "Company”), a clinical-stage precision oncology company, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback